Literature DB >> 22924623

Synthesis and antitumor activity evaluation of new asiatic acid derivatives.

Yan-Qiu Meng1, Yun-Yun Li, Feng-Qing Li, Yan-Ling Song, Hai-Feng Wang, Hong Chen, Bo Cao.   

Abstract

Twelve novel asiatic acid (AA) derivatives were designed and synthesized. Their structures were confirmed using NMR, MS, and IR spectra. Their in vitro cytotoxicities on various cancer cell lines (HeLa, HepG2, BGC-823, and SKOV3) were evaluated by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. Most of the derivatives were found to have stronger cell growth inhibitory activity than AA. Among them, compounds 5-8 and 11 with substituted amide group at C-28 exhibited more potent cytotoxicity than AA, Gefitinib, and etoposide (positive control).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22924623     DOI: 10.1080/10286020.2012.699961

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  3 in total

Review 1.  Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise.

Authors:  Mohamed Fizur Nagoor Meeran; Sameer N Goyal; Kapil Suchal; Charu Sharma; Chandragouda R Patil; Shreesh K Ojha
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

2.  Asiatic acid induces endoplasmic reticulum stress and apoptotic death in glioblastoma multiforme cells both in vitro and in vivo.

Authors:  Chandagirikoppal V Kavitha; Anil K Jain; Chapla Agarwal; Angela Pierce; Amy Keating; Kendra M Huber; Natalie J Serkova; Michael F Wempe; Rajesh Agarwal; Gagan Deep
Journal:  Mol Carcinog       Date:  2014-09-22       Impact factor: 4.784

3.  AA-PMe, a novel asiatic acid derivative, induces apoptosis and suppresses proliferation, migration, and invasion of gastric cancer cells.

Authors:  Yue Jing; Gang Wang; Ying Ge; Minjie Xu; Shuainan Tang; Zhunan Gong
Journal:  Onco Targets Ther       Date:  2016-03-17       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.